Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities
Net (loss) income	$ (83,697,000)	$ 23,798,000
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization	10,715,000	3,363,000
Provision for credit losses	1,230,000	0
Stock-based compensation	10,080,000	9,400,000
Loss on reserves	639,000	0
Impairment of assets	15,246,000	0
Realized loss (gain) on marketable securities	946,000	(1,018,000)
Amortization of premium and discount of marketable securities, net	(190,000)	3,750,000
Change in fair value of derivative	(290,000)	(69,000)
Change in fair value of common stock warrants liability	3,225,000	(29,531,000)
Change in fair value of earnout liability	703,000	(40,983,000)
Deferred tax provision (benefit)	640,000	(1,246,000)
Other non-cash expenses	518,000	615,000
Changes in operating assets and liabilities:
Accounts receivable and other receivables	(3,359,000)	(15,230,000)
Inventory	46,000	(912,000)
Prepaid expenses and other current assets	2,397,000	(4,994,000)
Other long-term assets	(4,750,000)	(12,761,000)
Accounts payable	373,000	909,000
Accrued expenses	(3,590,000)	4,985,000
Operating lease liability	(350,000)	(534,000)
Other liabilities, current	(1,362,000)	65,000
Other liabilities, long-term	0	38,000
Net cash used in operating activities	(50,830,000)	(60,355,000)
Cash flows from investing activities
License prepayment within other long-term assets	0	(7,913,000)
Purchases of property, plant, and equipment	(8,953,000)	(102,188,000)
Purchases of marketable securities	(1,817,317,000)	(3,626,305,000)
Sales of marketable securities	1,751,508,000	3,605,216,000
Maturities of marketable securities	103,321,000	157,422,000
Net cash provided by investing activities	28,559,000	26,232,000
Cash flows from financing activities
Payment of notes payable	(4,793,000)	0
Proceeds from Canadian Government Research and Development Program	8,097,000	0
Proceeds from exercise of stock options	252,000	146,000
Net cash provided by financing activities	3,556,000	146,000
Effects of foreign exchange rate changes on the balance of cash and cash equivalents, and restricted cash	(480,000)	1,131,000
Net decrease in cash, cash equivalents and restricted cash	(19,195,000)	(32,846,000)
Cash, cash equivalents and restricted cash, beginning of the year	75,502,000	108,348,000
Cash and cash equivalents at end of the year	56,307,000	75,502,000
Non-cash investing and financing activities
Purchases of fixed assets included in accounts payable and accrued expenses	1,308,000	1,939,000
Stock-based compensation capitalized into property, plant, and equipment	0	2,236,000
Accrued interest capitalized into property, plant, and equipment	0	367,000
Cash paid during the year
Income taxes payment	23,000	129,000
Interest payment	$ 1,708,000	$ 0